|Bid||19.14 x 0|
|Ask||19.16 x 0|
|Day's Range||18.32 - 19.70|
|52 Week Range||7.50 - 130.80|
|Beta (5Y Monthly)||1.40|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Despite recent troubles, Canopy Growth is optimistic its cannabis beverages can dwarf the growth of hard seltzers.
Aurora surprised investors with its better-than-expected Q3 results a couple of weeks ago. At the time of its Q3 update, over 19% of Aurora's outstanding shares were sold short. When Aurora beat expectations, it's a near-certainty that some of the short-sellers quickly moved to cover their losses by buying Aurora stock.
After Aurora Cannabis (NYSE: ACB) posted surprisingly positive Q3 results last week, some might have thought that Canopy Growth (NYSE: CGC) would have good news in its quarterly update this week. Canopy announced its fiscal 2020 fourth-quarter and full-year results on Friday and the marijuana stock fell more than 20% in intraday trading, which gives you an idea of how the company performed in Q4. Here are 10 things to hate about Canopy Growth's Q4 update, along with a couple of things to love.
Faced with bad assets and even more writedowns, Aurora Cannabis Inc (TSX:ACB)(NYSE:ACB) stock is looking ugly.The post Aurora Cannabis (TSX:ACB): The $1 Billion Question appeared first on The Motley Fool Canada.
Some of the top TSX cannabis stocks have seen a consistent surge in the last few months. Do you own these in your portfolio?The post Market Rally: Top TSX Cannabis Stocks for June 2020 appeared first on The Motley Fool Canada.
Some are high, some are low, so let's see where these three top cannabis producers fall with a $10,000 investment.The post Here’s How Much $10,000 Invested in Aurora, Canopy and Aphria Is Worth Today appeared first on The Motley Fool Canada.
Canadian cannabis kingpin Aurora Cannabis (NYSE: ACB) closed its acquisition of Massachusetts-based cannabidiol (CBD) maker Reliva LLC last night in a $40 million deal (or more than twice that, if Reliva hits certain financial milestones over the next couple of years). Aurora Cannabis stock plunged more than 10% as soon as trading resumed this morning and hasn't gained back much since -- down 8.5% as of 12:15 p.m. EDT. Aurora interim CEO Michael Singer says the merger will "create a market leading international cannabinoid platform that we believe can deliver robust revenue and profitable growth."
Inside the best performing stocks in the top cannabis ETF of May.
Aurora Cannabis' (NYSE: ACB) latest asset buy is in the books. The company announced on Thursday that its purchase of Reliva, a maker of hemp-derived cannabidiol (CBD) products, has closed. The news comes just over a week after Aurora divulged that it and Reliva had agreed to the acquisition.
In recent weeks, Aurora Cannabis (NYSE: ACB) stock has seen new life. It all started with the company releasing its third-quarter 2020 results on May 14, which showed 18% revenue growth from the prior period. Then, on May 20, the cannabis producer also announced it was acquiring Reliva, a cannabidiol (CBD) brand that would allow it to penetrate the U.S. market.
Hexo Corp (TSX:HEXO)(NYSE:HEXO) and Aphria Inc (TSX:APHA)(NYSE:APHA) could be better buys in the growing industry.The post Interested in Aurora Cannabis Stock? Try These Companies Instead appeared first on The Motley Fool Canada.
Vapes and chocolate edibles are among the new cannabis products the company is rolling out to medical marijuana consumers.
Well, here's a twist: The COVID-19 pandemic might have dragged down most sectors, but it is lifting up marijuana stocks for sure. Edmonton, Alberta-based Aurora Cannabis (NYSE: ACB) saw strong demand after Canada legalized recreational marijuana in 2018. External factors including black-market sales and a slow rollout of stores post-legalization made it harder for the company to make a profit; ultimately, investors lost trust, and the stock kept sinking below $1 -- to the point that it was at risk of being delisted from the New York Stock Exchange.
Though marijuana sales have been blazing-hot during the coronavirus pandemic, don't get too high on the monthly sales figures.
When the Canadian cannabis producer uses the word "profitable," it doesn't really mean profitable.
Last week's big cannabis company news was a throwback to the good old days of 2018 or so, with Aurora Cannabis (NYSE: ACB) signing on the dotted line for a buyout. Canada-based Aurora is reaching across the border for that acquisition. It announced it has agreed to buy U.S. hemp-derived cannabidiol (CBD) products maker Reliva in a deal for roughly $40 million in Aurora common stock, plus up to $45 million over the next two years in cash, stock, or a combination of the two if Reliva meets specific financial goals.
Cannabis stocks and ETFs jumped last week. Here's why.
Embattled cannabis cultivator Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) is highly uncertain and there is more turmoil ahead.The post Aurora Cannabis (TSX:ACB) Isn’t a Buy appeared first on The Motley Fool Canada.
Most Canadian licensed producers are likely sitting on underutilized or unused assets that they won't be able to move.
Canadian cannabis company Tilray's (NASDAQ: TLRY) CEO believes that at least 12 marijuana companies will go under this year. In March, Tilray announced that it would be raising $90.4 million through an offering, largely because the company still could. CEO Brendan Kennedy told BNN Bloomberg that he "wasn't sure anyone was going to be able to raise any money in this industry again" and that "when we had the opportunity to strengthen the balance sheet, we did."
Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) stock has surged after its Q3 2020 earnings release, while cannabis sales have surged during the pandemic.The post Aurora Cannabis (TSX:ACB) Stock: Is the Rally for Real? appeared first on The Motley Fool Canada.
The company's revenue was an improvement from the previous quarter, but Aurora still posted a loss.
Months before COVID-19, the marijuana industry was already plagued with problems. Investors lost interest in the Aurora Cannabis stock because of very poor performance. This weed stock is in danger of falling to $0 if it continues reporting lethargic results.The post Aurora Cannabis (TSX:ACB) Stock: $0 Is a Very Real Possibility appeared first on The Motley Fool Canada.
Aurora Cannabis (NYSE: ACB) stock has skyrocketed by a triple-digit percentage in recent days after the Canadian cannabis producer reported better-than-expected fiscal 2020 third-quarter results. You might think that after this huge gain, Aurora is outperforming rival Cronos Group (NASDAQ: CRON), which posted Q1 results earlier this month that were below expectations. Which of these two marijuana stocks is the better pick going forward?
As a result, many investors are increasingly looking for stability in a volatile stock market. One cannabis company that has been making a lot of noise over the past couple of weeks or so is none other than Aurora Cannabis (NYSE: ACB). Aurora posted a string of poor financial performances last year and earlier in 2020.